References
1. Dravet C. The core Dravet syndrome phenotype. Epilepsia . 2011;52 Suppl 2:3-9.
2. Huang CH, Hung PL, Fan PC, et al. Clinical spectrum and the comorbidities of Dravet syndrome in Taiwan and the possible molecular mechanisms. Sci Rep . 2021;11(1):20242.
3. Bagger FO, Kinalis S, Rapin N. BloodSpot: a database of healthy and malignant haematopoiesis updated with purified and single cell mRNA sequencing profiles. Nucleic Acids Res . 2019;47(D1):D881-D885.
4. Harvey RC, Mullighan CG, Chen IM, et al. Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. Blood . 2010;115(26):5312-5321.
5. Cramer-Morales K, Nieborowska-Skorska M, Scheibner K, et al. Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile. Blood . 2013;122(7):1293-1304.
6. Berkvens JJ, Veugen I, Veendrick-Meekes MJ, et al. Autism and behavior in adult patients with Dravet syndrome (DS). Epilepsy Behav . 2015;47:11-16.
7. Catterall WA. Dravet Syndrome: A Sodium Channel Interneuronopathy.Curr Opin Physiol . 2018;2:42-50.
8. Colasante G, Lignani G, Brusco S, et al. dCas9-Based Scn1a Gene Activation Restores Inhibitory Interneuron Excitability and Attenuates Seizures in Dravet Syndrome Mice. Mol Ther . 2020;28(1):235-253.
9. Antonucci R, Vacca N, Ghisu E, et al. Acute lymphoblastic leukemia in a nine-year-old girl with isodicentric chromosome 15 syndrome.Cancer Genet . 2019;235-236:93-94.
10. Chiang HL, Liu CJ, Hu YW, et al. Risk of cancer in children, adolescents, and young adults with autistic disorder. J Pediatr . 2015;166(2):418-423 e411.
11. Gannon WT, Martinez JE, Anderson SJ, Swingle HM. Cancer and copy number variants in an autism diagnostic clinic. J Dev Behav Pediatr . 2013;34(5):379-381.
12. Tyler CV, Schramm SC, Karafa M, Tang AS, Jain AK. Chronic disease risks in young adults with autism spectrum disorder: forewarned is forearmed. Am J Intellect Dev Disabil . 2011;116(5):371-380.
13. Blatt J, Deal AM, Mesibov G. Autism in children and adolescents with cancer. Pediatr Blood Cancer . 2010;54(1):144-147.
14. Vuattoux D, Colomer-Lahiguera S, Fernandez PA, et al. Cancer Care of Children, Adolescents and Adults With Autism Spectrum Disorders: Key Information and Strategies for Oncology Teams. Front Oncol . 2020;10:595734.
15. Wen Y, Herbert MR. Connecting the dots: Overlaps between autism and cancer suggest possible common mechanisms regarding signaling pathways related to metabolic alterations. Med Hypotheses . 2017;103:118-123.
16. Liu DC, Eagleman DE, Tsai NP. Novel roles of ER stress in repressing neural activity and seizures through Mdm2- and p53-dependent protein translation. PLoS Genet . 2019;15(9):e1008364.
17. Riahi-Zanjani B, Delirrad M, Fazeli-Bakhtiyari R, et al. Hematological Consequences of Valproic Acid in Pediatric Patients: A Systematic Review with a Mechanistic Approach. CNS Neurol Disord Drug Targets . 2022;21(4):316-325.
18. Williams DC, Jr., Massey GV, Russell EC, Riley RS, Ben-Ezra J. Translocation-positive acute myeloid leukemia associated with valproic acid therapy. Pediatr Blood Cancer . 2008;50(3):641-643.